The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...
The FDA granted accelerated approval to atacicept-vymj for proteinuria reduction in adults with primary immunoglobulin A ...
ORIGIN 3 randomized 431 biopsy‑confirmed IgAN patients 1:1; atacicept 150 mg weekly SC produced the largest placebo‑adjusted UPCR reduction reported at week 36. Accelerated approval hinged on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results